
Sign up to save your podcasts
Or
In this episode, Greg and Rob discuss a recent publication regarding how 340B Program participation may impact the degree of biosimilar utilization. Additionally, the guys recap recent legislative proposals with 340B impact that were advanced by the House Energy & Commerce Committee.
Article citation: Health Affairs 42, NO. 5 (2023): 632–641
5
3232 ratings
In this episode, Greg and Rob discuss a recent publication regarding how 340B Program participation may impact the degree of biosimilar utilization. Additionally, the guys recap recent legislative proposals with 340B impact that were advanced by the House Energy & Commerce Committee.
Article citation: Health Affairs 42, NO. 5 (2023): 632–641
4,316 Listeners
77,216 Listeners
43,255 Listeners
111,521 Listeners
56,149 Listeners
5,972 Listeners
20 Listeners
57,550 Listeners
15,228 Listeners
7 Listeners
17,049 Listeners
0 Listeners
407 Listeners
3 Listeners
10,401 Listeners